A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

SixFix Circular Fixation System Launches

The Disruptive SixFix™ System and Software Shortens Surgical Time, Simplifies Inventory, and Enhances Post-Operative Patient Care Reports AMDT Holdings

AMDT Holdings, Inc. develops disruptive products to address existing and emerging needs in the extremity market. The clinical use of the SixFix Circular Fixation System began in January, 2020. Initial surgeries were conducted in Tennessee and Ohio with successful surgeries in the treatment of foot and ankle deformities.

The SixFix™ Circular Fixation System is a platform that can address extremity applications in trauma, foot and ankle, and deformity correction for both adults and pediatrics. The SixFix™ System introduces a unique design in which one compact pre-assembled unit of six (6) struts are ready for sterilization and use right out of the box. The strut assembly unfolds to easily connect the rings and eliminates difficult strut exchanges by providing a full range of lengths with a single strut design.

An advanced component of the SixFix™ Circular System is the optional, patented software enabling deformity analysis and correction. A surgeon with two (2) patient radiographs utilizes the unique capabilities of the software to create a prescription that will achieve a corrected deformity and a healed fracture. The SixFix™ software recognizes the six (6) radiopaque fiducial markers that are an integral feature of the SixFix™ fixator with which the software can create an accurate 3D image of the fixator and the deformity. The unique capabilities of the software reduce surgeon input to known values such as ring size and strut length. The software is also able to correct for non-orthogonal radiographs, perspective distortion and variations in radiograph focal point – all of which introduce errors into the common radiograph.

The SixFix™ System will be featured in the Technology Theater (#1769) during the 2020 AAOS Annual Meeting in Orlando on Thursday, March 26th at 9:45 AM. Michael Mullaney, Vice President of Product Development for AMDT Holdings, will present an overview of the disruptive technology within the SixFix™ System software and hardware.

Stephen J. Frania, DPM, FACFAS, a surgeon in Mentor, Ohio, who specializes in reconstructive foot and ankle surgery including lower limb deformity correction, says, “Each strut in the pre-assembled SixFix™ strut assembly is able to extend from 100mm to 300mm. Because I did not have to be concerned about switching out struts intra-operatively as I have with other designs, the application of the frame was fast and easy. At the end of the surgery, I was able to maintain the slim profile of the strut assembly by removing those strut add-ons not required to achieve the final correction.”

Bhekumuzi M. Khumalo, DPM, a foot and ankle surgeon in Union City, TN commented that the SixFix™ Circular Fixation System enabled him to “quickly and easily manipulate the frame to address the deformity by releasing then locking the struts by sliding a locking ring on each strut. This ease of use is important for me since I cannot rely on residents or fellows to lend intra-operative assistance.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy